Led by Elizabeth Rosolowsky, MD, the TrialNet team at the Govenors of the University of Alberta is dedicated to preventing type 1 diabetes and stopping disease progression by preserving insulin production before and after diagnosis.

Note: As a TrialNet affiliate, the Govenors of the University of Alberta is regionally overseen by The Hospital for Sick Children. If you reach out to TrialNet, you may be contacted by staff from either institution. 

Led by Anuj Bhargava, MD, MBA, CDCES, FACP, FACE, the TrialNet team at Iowa Diabetes is dedicated to preventing type 1 diabetes and stopping disease progression by preserving insulin production before and after diagnosis.

Note: As a TrialNet affiliate, Iowa Diabetes is regionally overseen by University of Minnesota. If you reach out to TrialNet, you may be contacted by staff from either institution. 

Led by Elizabeth Cummings, MD, the TrialNet team at IWK Health Center is dedicated to preventing type 1 diabetes and stopping disease progression by preserving insulin production before and after diagnosis.

Note: As a TrialNet affiliate, IWK Health Center is regionally overseen by The Hospital for Sick Children. If you reach out to TrialNet, you may be contacted by staff from either institution. 

Led by David Hansen, MD, MPH, the TrialNet team at Joslin Center at SUNY Upstate Medical University is dedicated to preventing type 1 diabetes and stopping disease progression by preserving insulin production before and after diagnosis.

Note: As a TrialNet affiliate, Joslin Center at SUNY Upstate Medical University is regionally overseen by Columbia University. If you reach out to TrialNet, you may be contacted by staff from either institution

Joslin Diabetes Center is one of seventeen Type 1 Diabetes TrialNet International Clinical Centers at the forefront of type 1 diabetes research. Led by Jason Gaglia, MD, MMSc, the TrialNet team at Joslin Diabetes Center is dedicated to preventing type 1 diabetes and stopping disease progression by preserving insulin production before and after diagnosis.

Led by Steven D. Kunkel, MD, the TrialNet team at Kadlec Medical Center Diabetes Learning Center is dedicated to preventing type 1 diabetes and stopping disease progression by preserving insulin production before and after diagnosis. 

Note: As a TrialNet affiliate, Kadlec Medical Center Diabetes Learning Center is regionally overseen by Benaroya Research Institute. If you reach out to TrialNet, you may be contacted by staff from either institution. 

Led by Ana Creo, MD, the TrialNet team at Mayo Clinic is dedicated to preventing type 1 diabetes and stopping disease progression by preserving insulin production before and after diagnosis.

Note: As a TrialNet affiliate, Mayo Clinic is regionally overseen by University of Minnesota. If you reach out to TrialNet, you may be contacted by staff from either institution. 

Led by Susanne Cabrera, MD, the TrialNet team at Medical College of Wisconsin is dedicated to preventing type 1 diabetes and stopping disease progression by preserving insulin production before and after diagnosis.

Note: As a TrialNet affiliate, Medical College of Wisconsin is regionally overseen by Indiana University - Riley Hospital. If you reach out to TrialNet, you may be contacted by staff from either institution.

Led by Amit Lahoti, MD, the TrialNet team at Nationwide Children’s Hospital/ Children's Research Institute is dedicated to preventing type 1 diabetes and stopping disease progression by preserving insulin production before and after diagnosis.

Led by Rodica Busui MD, PhD, the TrialNet team at Oregon Health and Science University is dedicated to preventing type 1 diabetes and stopping disease progression by preserving insulin production before and after diagnosis.

Note: As a TrialNet affiliate, Oregon Health and Science University is regionally overseen by Benaroya Research Institute. If you reach out to TrialNet, you may be contacted by staff from either institution